Singapore markets closed
Straits Times Index
3,292.93 -3.96 (-0.12%) Nikkei
38,236.07 -37.98 (-0.10%) Hang Seng
18,475.92 +268.79 (+1.48%) FTSE 100
8,213.49 +41.34 (+0.51%) Bitcoin USD
63,363.73 +586.98 (+0.94%) CMC Crypto 200
1,315.40 +38.42 (+3.01%)
Inovio Pharmaceuticals, Inc. (INO)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 12.01 |
| Open | 12.32 |
| Bid | 12.08 x 100 |
| Ask | 12.15 x 200 |
| Day's range | 11.90 - 12.45 |
| 52-week range | 3.84 - 14.75 |
| Volume | |
| Avg. volume | 469,295 |
| Market cap | 313.47M |
| Beta (5Y monthly) | 1.12 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Does Inovio (INO) Have the Potential to Rally 122.92% as Wall Street Analysts Expect?
The consensus price target hints at a 122.9% upside potential for Inovio (INO). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
- Insider Monkey
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q4 2023 Earnings Call Transcript
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q4 2023 Earnings Call Transcript March 6, 2024 Inovio Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-1.12, expectations were $-1.58. Inovio Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon, ladies and […]
- Thomson Reuters StreetEvents
Q4 2023 Inovio Pharmaceuticals Inc Earnings Call
Q4 2023 Inovio Pharmaceuticals Inc Earnings Call
© 2024 Yahoo. All rights reserved.